Filing Flows

Filing Flows › Companies › Prestige Consumer Healthcare › Cash flow

Prestige Consumer Healthcare cash flow, quarter by quarter

Latest: Q2 FY27 · from the cash-flow statements filed with the SEC

Free cash flow$34.2M in Q2 FY27 · $214M over twelve months

Operating cash flow$37.9M
Capital spending−$3.6M
Free cash flow+$34.2M
Cash / net income1.5×
Cash conversion cycle140 days

Analysis

In Q2 FY27, Prestige Consumer Healthcare generated $37.9M of operating cash flow and spent $3.6M on capital projects, leaving free cash flow of $34.2M. That is $21.1M less than in Q2 FY26 ($55.4M).

Over the twelve months to Sep 30, 2026, operating cash flow was $230M; the largest uses were acquisitions ($1.3B), buybacks ($46.5M), net borrowing (+) / repaid (−) ($32.6M); besides operations, cash came from other financing ($1.1B), shares issued ($472K); the cash balance fell by $72.6M.

Operating cash flow was $37.9M against net income of $25.3M — 1.5× profit, cash ran ahead of reported earnings. The largest differences: receivables −$48.8M, deferred taxes +$15.3M, accrued liabilities +$14.2M.

Its cash conversion cycle was 140 days (receivables 59 + inventory 104 − payables 23).

Free cash flow

Prestige Consumer Healthcare: free cash flow by quarterPrestige Consumer Healthcare: free cash flow by quarter$63.5MQ3 FY25$58.4MQ4 FY25$78.2MQ1 FY26$55.4MQ2 FY26$75.3MQ3 FY26$37.6MQ4 FY26$67.1MQ1 FY27$34.2MQ2 FY27
Operating cash flow less capital spending.
Prestige Consumer Healthcare: operating cash flow against capital spendingPrestige Consumer Healthcare: operating cash flow against capital spendingOperating cash flowCapital spending$65.1M$1.6MQ3 FY25$61.8M$3.5MQ4 FY25$79.0M$838KQ1 FY26$57.5M$2.1MQ2 FY26$78.3M$3.0MQ3 FY26$42.8M$5.2MQ4 FY26$70.8M$3.7MQ1 FY27$37.9M$3.6MQ2 FY27
Latest (Q2 FY27): Operating cash flow $37.9M, Capital spending $3.6M.

Capital allocation, year by year

Prestige Consumer Healthcare: where the cash came from (up) and went (down), by fiscal yearPrestige Consumer Healthcare: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsBuybacksFY22: Operating cash flow $260MFY22: Net borrowing −$2.6MFY22: Shares issued $7.0MFY22: Capital spending −$9.6MFY22: Acquisitions −$247M$267MFY22FY23: Operating cash flow $230MFY23: Net borrowing −$138MFY23: Shares issued $7.4MFY23: Capital spending −$7.8MFY23: Buybacks −$50.0M$237MFY23FY24: Operating cash flow $249MFY24: Net borrowing −$228MFY24: Shares issued $18.1MFY24: Capital spending −$9.6MFY24: Acquisitions −$10.6MFY24: Buybacks −$25.0M$267MFY24FY25: Operating cash flow $252MFY25: Net borrowing −$140MFY25: Shares issued $14.8MFY25: Capital spending −$8.2MFY25: Acquisitions −$8.2MFY25: Buybacks −$51.5M$266MFY25FY26: Operating cash flow $258MFY26: Shares issued $4.3MFY26: Capital spending −$11.2MFY26: Acquisitions −$124MFY26: Buybacks −$156M$262MFY26
Over these 5 years operating cash flow totalled $1.2B; the largest uses were net borrowing ($508M) and acquisitions ($390M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$46.5M
Debt$994M
Net debt$947M
Due within a year$10.4M

Prestige Consumer Healthcare funds itself: free cash flow was $214M over the last twelve months, and $46.5M of cash and investments stands against $994M of debt ($10.4M due within a year, 4.5× covered by cash).

Prestige Consumer Healthcare: debt maturities by year (FY26)Prestige Consumer Healthcare: debt maturities by year (FY26)$400MYear 2$600MAfter year 5
Principal due in each year as disclosed in the annual report, against $46.5M of cash and investments now.

Where the cash came from and went

Prestige Consumer Healthcare: sources (+) and uses (−) of cash, Q2 FY27Prestige Consumer Healthcare: sources (+) and uses (−) of cash, Q2 FY27Acquisitions−$149MOther financing$58.9MCash drawn (+) / kept (−)$42.6MOperating cash flow$37.9MOther investing$13.3MCapital spending−$3.6MNet borrowing (+) / repaid (−)−$655KExchange rates$130KShares issued$94KTaxes on employees’ shares−$23K
Prestige Consumer Healthcare: sources (+) and uses (−) of cash, TTM to Q2 FY27Prestige Consumer Healthcare: sources (+) and uses (−) of cash, TTM to Q2 FY27Acquisitions−$1.3BOther financing$1.1BOperating cash flow$230MCash drawn (+) / kept (−)$72.6MBuybacks−$46.5MNet borrowing (+) / repaid (−)−$32.6MCapital spending−$15.6MTaxes on employees’ shares−$2.8MOther investing−$1.8MShares issued$472KExchange rates$323K

From profit to cash

Prestige Consumer Healthcare: net income to operating cash flow, Q2 FY27Prestige Consumer Healthcare: net income to operating cash flow, Q2 FY27Net income$25.3MDepreciation & amortization$12.0MStock-based pay$1.2MDeferred taxes$15.3MGains on disposals$142KReceivables−$48.8MInventory$6.4MPayables$2.6MAccrued liabilities$14.2MPrepaid and other assets−$7.7MOperating cash flow$37.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 FY275910423140
Q1 FY276512321167
Q4 FY266110722147
Q3 FY266311831150
Q2 FY266211724155
Q1 FY266612517174
Q4 FY255510614148
Q3 FY255211018144

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 FY27$37.9M−$3.6M−$149M—−$655K$94K$42.6M$34.2M
Q1 FY27$70.8M−$3.7M−$1.0B—$1.0B—−$25.3M$67.1M
Q4 FY26$42.8M−$5.2M$1.8M−$690K−$711K$378K−$1.5M$37.6M
Q3 FY26$78.3M−$3.0M−$126M−$45.8M−$624K—$56.7M$75.3M
Q2 FY26$57.5M−$2.1M—−$75.0M−$539K$752K$20.4M$55.4M
Q1 FY26$79.0M−$838K—−$34.8M−$608K$3.2M−$41.6M$78.2M
Q4 FY25$61.8M−$3.5M—−$11.3M−$2.6M$2.5M−$47.0M$58.4M
Q3 FY25$65.1M−$1.6M—−$2.4M−$60.2M$8.7M$666K$63.5M

Prestige Consumer Healthcare: income statement and cash flow

Prestige Consumer Healthcare, Q2 FY27: revenue $336M (+23% year over year), operating margin 24.0%. The chart follows the revenue to costs, profit and cash.

Prestige Consumer Healthcare: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.